Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis

Bone

Volumn 30, Issue 2, 2002, Pages 340-346

  Romas, E ^a   Gillespie, M T ^b   Martin, T J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

(TNF ); Osteoclast; Receptor activator of NF B (RANK) ligand; Rheumatoid arthritis (RA); T cells; Tumor necrosis factor

Indexed keywords

CD40 LIGAND; CHEMOKINE; CYCLOSPORIN A; CYTOKINE; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; POLYPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

BONE ATROPHY; BONE EROSION; FIBROBLAST; HUMAN; JOINT DESTRUCTION; MACROPHAGE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; GLYCOPROTEINS; HUMANS; OSTEOCLASTS; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036172368     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00682-2     Document Type: Review

References (87)

1. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
2. TNF-α induces differentiation of and bone resorption by osteoclasts
3. Osteoprotegerin mitigates tail suspension-induced osteopenia
4. A germinal center-like reaction in the nonlymphoid tissue of the synovial membrane
5. + T cells as a marker of disease activity in rheumatoid arthritis
6. Arthritis patterns in Lewis rats with adjuvant-induced arthritis define distinct mechanisms of joint protection for IL-1ra, sTNFR-I and OPG
7. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint
8. Severe inflammatory arthritis and lymphadenopathy in the absence of TNF
9. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
10. Interleukin-18, rheumatoid arthritis, and tissue destruction
11. Cytokine and direct cell-contact in synovitis - relevance to therapeutic intervention
12. Vasoactive intestinal protein prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
13. VIP and PACAP stimulate the induction of Th2 responses by up-regulating B7.2 expression
14. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells
15. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis
16. Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats
17. Rheumatoid arthritis
18. The role of T cells in the immunopathogenesis of rheumatoid arthritis; New perspectives
19. The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, TNFα, and GM-CSF) on human osteoclast formation from circulating cells
20. Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis
21. A proinflammatory role for IL-18 in rheumatoid arthritis
22. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
23. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
24. Ligation of CD40 induced tumor necrosis factor-α in rheumatoid arthritis; A novel mechanism of activation of synoviocytes
25. Rheumatoid arthritis. Pathophysiology and implications for therapy
26. Interleukin-1β and tumor necrosis factor-α but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
27. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
28. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
29. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor
30. Activated T cells support osteoclast formation in vitro
31. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro
32. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
33. Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent
34. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
35. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis
36. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene
37. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent
38. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig
39. Tumor necrosis factor-α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
40. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor κB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture
41. The RANK/RANK ligand/OPG system in cartilage
42. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
43. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
44. Activated human T cells directly induce osteoclastogenesis from human monocytes; Possible role of T cells in bone destruction in rheumatoid arthritis patients
45. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
46. Mechanisms of tissue destruction in rheumatoid arthritis
47. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover
48. TNFα induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
49. The erosive front; A topographic study of the junction between the pannus and the subchondral plate in macerated rheumatoid metacarpal head
50. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
51. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosions
52. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis
53. Evidence for a role of a tumor necrosis factor (TNFα) converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival
54. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis
55. Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells
56. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis
57. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice
58. Clinical improvement and radiological deterioration in rheumatoid arthritis; Evidence that the pathogenesis of synovial inflammation and articular erosion may differ
59. Collagen-induced arthritis, an animal model of autoimmunity
60. Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation
61. Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation
62. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis
63. Membrane-type-1 matrix metalloproteinase is abundantly expressed in fibroblasts and osteoclasts at the bone-implant interface of aseptically loosened joint arthroplasties in situ
64. Fibroblastic stromal cells express receptor activator of NFκB ligand and support osteoclast differentiation
65. Therapeutic approaches to bone diseases
66. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis
67. Fc-Osteoprotegerin fusion protein (Fc-OPG) reduces osteoclast numbers and prevents bone destruction in rats with collagen-induced arthritis
68. RANKing the importance of measles virus in Paget's disease
69. Glucocorticoid decreases circulating osteoprotegerin (OPG); Possible mechanism for glucocorticoid induced osteoporosis
70. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10; Possible relevance to pathophysiology of rheumatoid arthritis
71. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation
72. Expression of osteoclast differentiation factor in rheumatoid arthritis
73. Efficacy and safety of leflunomide in active rheumatoid arthritis
74. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
75. Osteoclast-like cells in murine collagen induced arthritis
76. Involvement of receptor activator of nuclear factorκB/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
77. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts
78. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma
79. Bone resorption by osteoclasts
80. Tumor necrosis factors α and β induce osteoblastic cells to stimulate osteoclastic bone resorption
81. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group
82. Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin
83. +, CD28-T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems
84. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18
85. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms
86. Cartilage destruction and bone erosion in arthritis; The role of tumour necrosis factor alpha
87. Pathogenesis of rheumatoid arthritis; The role of synoviocytes